Hepatic steatosis common. Biliary cirrhosis and portal hypertension (CF liver disease). Risk of gallstones. Drug‐induced liver injury (e.g., from antibiotics, CFTR modulators). The gene discussed is CFTR; the disease is fatty liver disease.